Loading…

Free Energy Perturbation Approach for Accurate Crystalline Aqueous Solubility Predictions

Early assessment of crystalline thermodynamic solubility continues to be elusive for drug discovery and development despite its critical importance, especially for the ever-increasing fraction of poorly soluble drug candidates. Here we present a detailed evaluation of a physics-based free energy per...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2023-12, Vol.66 (23), p.15883-15893
Main Authors: Hong, Richard S., Rojas, Ana V., Bhardwaj, Rajni Miglani, Wang, Lingle, Mattei, Alessandra, Abraham, Nathan S., Cusack, Kevin P., Pierce, M. Olivia, Mondal, Sayan, Mehio, Nada, Bordawekar, Shailendra, Kym, Philip R., Abel, Robert, Sheikh, Ahmad Y.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Early assessment of crystalline thermodynamic solubility continues to be elusive for drug discovery and development despite its critical importance, especially for the ever-increasing fraction of poorly soluble drug candidates. Here we present a detailed evaluation of a physics-based free energy perturbation (FEP+) approach for computing the thermodynamic aqueous solubility. The predictive power of this approach is assessed across diverse chemical spaces, spanning pharmaceutically relevant literature compounds and more complex AbbVie compounds. Our approach achieves predictive (RMSE = 0.86) and differentiating power (R 2 = 0.69) and therefore provides notably improved correlations to experimental solubility compared to state-of-the-art machine learning approaches that utilize quantum mechanics-based descriptors. The importance of explicit considerations of crystalline packing in predicting solubility by the FEP+ approach is also highlighted in this study. Finally, we show how computed energetics, including hydration and sublimation free energies, can provide further insights into molecule design to feed the medicinal chemistry DMTA cycle.
ISSN:0022-2623
1520-4804
DOI:10.1021/acs.jmedchem.3c01339